Anika Therapeutics, Inc. (ANIK) Net margin 2016–2025
Anika Therapeutics, Inc. (ANIK) net profit margin by fiscal year — reported net income divided by reported revenue.
-9.6%FY2025 · since FY2016: 31.5% → -9.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -9.6% | +37.4 pp |
| FY2024 | -47.0% | +21.4 pp |
| FY2023 | -68.4% | -55.4 pp |
| FY2022 | -13.1% | -15.9 pp |
| FY2021 | 2.8% | +21.2 pp |
| FY2020 | -18.4% | -42.1 pp |
| FY2019 | 23.7% | +6.0 pp |
| FY2018 | 17.7% | -10.3 pp |
| FY2017 | 28.1% | -3.4 pp |
| FY2016 | 31.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice